Safety Regulation #34

March 19, 2019 | by Dr. Paul Zickler

Members shall operate the international pharmacy operations in an open and transparent fashion. At the point of sale members must ensure that patients are informed regarding the country where the medication is approved for sale and the country or countries from where it may be dispensed.

The contents on DoctorSolve.com are meant to provide useful and relevant information. The information on our website is intended for educational purposes and may include text, graphics, video and other multimedia. The information on this website should not be used as a substitute for professional medical advice, diagnosis or treatment. Always consult your doctor or other medical practitioner before taking any course of action based on the information you find on DoctorSolve.com.

About Author

Dr. Paul Zickler

Dr. Paul Zickler graduated from the faculty of medicine at the University of Western Ontario in 1972 and became an Emergency Physician. He practiced as an Emergency Physician for 18 years after which he co-owned and operated several ambulatory medical and travel clinics for 12 years and discovered his interest in prescription medicines. Dr. Zickler was a founding member of the Canadian International Pharmacy Association (CIPA) and was CIPA’s Vice-president for Medical Affairs. He has also served as an Associate Professor of Emergency Medicine at the University of British Columbia, the Director of Professional Programs for the Justice Institute of British Columbia (paramedic academy) and was the principal investigator for Phase 2 and 3 studies researching vaccines.

All posts by Dr. Paul Zickler